CG
GOSS icon

Cutler Group’s Gossamer Bio GOSS Stock Holding History

Cutler Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18
Closed -$1K – 3983
2023
Q2 		$1K Buy
18
+7
+64% +$697 ﹤0.01% 3281
2023
Q1 		$1K Sell
11
-61
-85% -$9.34K ﹤0.01% 3429
2022
Q4 		$12K Buy
72
+39
+118% +$25.7K ﹤0.01% 2578
2022
Q3 		$31K Buy
33
+27
+450% +$26.8K ﹤0.01% 2272
2022
Q2 		$3K Buy
+6
New +$3.72K ﹤0.01% 4045
2021
Q3 		– Sell
-19
Closed -$12K – 5939
2021
Q2 		$12K Buy
+19
New +$13.2K ﹤0.01% 3737
2020
Q4 		– Sell
-31
Closed -$31K – 5056
2020
Q3 		$31K Buy
+31
New +$32.9K ﹤0.01% 2131
2020
Q2 		– Sell
-5
Closed -$4K – 4559
2020
Q1 		$4K Sell
5
-11
-69% -$11.5K ﹤0.01% 3183
2019
Q4 		$20K Buy
+16
New +$25.8K ﹤0.01% 2209

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Cutler Group's GOSS Position: Q3 2023 in Review

Cutler Group sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 18 shares — an estimated $1K sold.

Cutler Group first reported a position in GOSS in Q4 2019 and held it in 9 quarters. The position peaked at $31K in Q3 2022. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Cutler Group reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 18 Gossamer Bio shares in Q3 2023, an estimated $1K.
  • Cutler Group first reported a position in Gossamer Bio in Q4 2019 and held it in 9 quarters.
  • Cutler Group's Gossamer Bio position peaked at $31K in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.